SB0003 — Health: pharmaceuticals; prescription drug cost and affordability review act; create. Creates new act.

Sponsors: Darrin Camilleri, Stephanie Chang, John Cherry

Current stage: Referred to a committee (Official Source)

Last reported event: Referred To Committee On Government Operations, recorded Apr 24, 2025 (Official Source)

Jurisdiction: MI

  1. Recorded Jan 8, 2025: Introduced By Senator Darrin Camilleri
  2. Recorded Jan 8, 2025: Referred To Committee On Finance, Insurance, And Consumer Protection
  3. Recorded Jan 23, 2025: Senate Co-sponsor(s) Named: Stephanie Chang
  4. Recorded Apr 24, 2025: Reported Favorably With Substitute (s-1) 4/23/2025
  5. Recorded Apr 24, 2025: Referred To Committee Of The Whole With Substitute (s-1)
  6. Recorded Apr 24, 2025: Rules Suspended For Immediate Consideration
  7. Recorded Apr 24, 2025: Reported By Committee Of The Whole Favorably With Substitute (s-1)
  8. Recorded Apr 24, 2025: Substitute (s-1) Concurred In
  9. Recorded Apr 24, 2025: Placed On Order Of Third Reading With Substitute (s-1)
  10. Recorded Apr 24, 2025: Rules Suspended
  11. Recorded Apr 24, 2025: Placed On Immediate Passage
  12. Recorded Apr 24, 2025: Amendment(s) Defeated
  13. Recorded Apr 24, 2025: Amendment(s) Adopted
  14. Recorded Apr 24, 2025: Passed Roll Call # 68 Yeas 20 Nays 15 Excused 1 Not Voting 1
  15. Recorded Apr 24, 2025: Received On 04/24/2025
  16. Recorded Apr 24, 2025: Read A First Time
  17. Recorded Apr 24, 2025: Referred To Committee On Government Operations

No plain-language summary is available yet.

  • Administrators
  • Families
  • School boards
  • Teachers and instructional staff

No key changes have been identified yet.

View source document

Sign up for full impact analysis

Liberty Bridge
Sign In

Loading document...

Loading notice…

Legislative data provided by LegiScan (legiscan.com), licensed under CC BY 4.0